Welcome to DU!
The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards.
Join the community:
Create a free account
Support DU (and get rid of ads!):
Become a Star Member
Latest Breaking News
General Discussion
The DU Lounge
All Forums
Issue Forums
Culture Forums
Alliance Forums
Region Forums
Support Forums
Help & Search
Clinton targets Valeant price hikes in campaign appearance
Source: Reuters
Homepage | Thu Jan 28, 2016 5:11pm EST
Clinton targets Valeant price hikes in campaign appearance
BY DEENA BEASLEY
Shares of Valeant Pharmaceuticals International Inc (VRX.N) fell on Thursday after the campaign of Democratic presidential contender Hillary Clinton posted a blog from an Iowa event detailing exorbitant price hikes for a migraine drug made by the company.
At an Iowa town hall over the weekend, Clinton read from a letter saying that the list price for 10 vials of migraine drug D.H.E. 45 had increased to more than $14,000 in December, compared with just over $3,000 in June of 2014.
"This is predatory pricing. It is unjustified. It is wrong," Clinton said, according to the post.
Officials at Valeant did not immediately respond to requests for comment.
Shares of Valeant fell nearly 9 percent to close at $86.12 on the New York Stock Exchange. More than 3 million shares of Valeant traded in the last hour of trading; total volume on the day was 7.9 mln shares.
[font size=1]-snip-[/font]
Clinton targets Valeant price hikes in campaign appearance
BY DEENA BEASLEY
Shares of Valeant Pharmaceuticals International Inc (VRX.N) fell on Thursday after the campaign of Democratic presidential contender Hillary Clinton posted a blog from an Iowa event detailing exorbitant price hikes for a migraine drug made by the company.
At an Iowa town hall over the weekend, Clinton read from a letter saying that the list price for 10 vials of migraine drug D.H.E. 45 had increased to more than $14,000 in December, compared with just over $3,000 in June of 2014.
"This is predatory pricing. It is unjustified. It is wrong," Clinton said, according to the post.
Officials at Valeant did not immediately respond to requests for comment.
Shares of Valeant fell nearly 9 percent to close at $86.12 on the New York Stock Exchange. More than 3 million shares of Valeant traded in the last hour of trading; total volume on the day was 7.9 mln shares.
[font size=1]-snip-[/font]
Read more: http://www.reuters.com/article/us-usa-election-clinton-valeant-pharms-idUSKCN0V62W4
4 replies
= new reply since forum marked as read
= new reply since forum marked as read
